Patents Assigned to Perception Neuroscience, Inc.
  • Patent number: 11426367
    Abstract: The disclosure provides a method of treating a substance use disorder in a subject, comprising administering to the subject a therapeutically effective amount of a composition comprising R(?)-ketamine or a pharmaceutically acceptable salt thereof, wherein the composition is substantially free of S(+)-ketamine or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 3, 2019
    Date of Patent: August 30, 2022
    Assignee: Perception Neuroscience, Inc.
    Inventors: Jeffrey M. Witkin, Jonathan Sporn, Jay D. Kranzler